Clinical trial
Phase III Randomized Study of SYNSORB Pk in Children With E. Coli-Associated…
NCT00004465 · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH · Terminated
Key facts
| NCT number | NCT00004465 |
|---|---|
| Title | Phase III Randomized Study of SYNSORB Pk in Children With E. Coli-Associated Hemolytic Uremic Syndrome |
| Official title | Phase III Randomized Study of SYNSORB Pk in Children With E. Coli-Associated |
| Lead sponsor | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH |
| Collaborators | Long Island Jewish Medical Center |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Hemolytic Uremic Syndrome |
| Intervention type | Drug |
| Interventions | SYNSORB Pk, Placebo |
| Enrollment | 145 |
| Start date | Jul 27, 1997 |
| Primary completion | Apr 14, 2001 |
| Completion | Apr 14, 2001 |
| First posted | Oct 19, 1999 |
| Last update posted | Jun 1, 2017 |
| Countries | Canada, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: